Furthermore, it benefits from a strong competitive edge, thanks to its relationships with third-party payers, patients, and physicians. And with long-term trends like the world's aging population, ...

Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...

Scientists used CRISPR technology to disable the cholesterol gene in a groundbreaking study, though widespread availability ...

Here are five medical breakthroughs that gave us hope in 2025. In February, a baby with a rare, often fatal genetic disorder ...

A dire wolf de-extinction debate, CRISPR-GPT for gene editing, and more topped the list of our most popular stories in ...

Here is the full list of the biotech and pharma Startup Battlefield 200 selectees, along with a note on what made us select ...

CRISPR Therapeutics (NASDAQ: CRSP) soared a few years ago, climbing more than 200% from the start of 2020 through early 2021, ...

Focusing on the futuristic tech that appears in sci-fi without paying attention to the actual point of the story is a big ...

The popular nursery rhyme This Little Piggy is an early childhood memory for many of us. It’s a poem that involves five little piggies, each corresponding to one of our fingers or toes. Kids love it, ...

We carry these mixed feelings into 2026, which is slated to be another great—yet perhaps troubled—year for science. No list ...

It was the best of times, it was the worst of times for research in 2025. | It was the best of times and it was the worst of times for research in 2025. Medical breakthroughs and stunning discoveries ...

O 15, 2025, Barclays analyst Luke Sergott raised the price target for TXG from $17 to $22 while maintaining an Overweight ...